Company: HYAC-WT
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001410578-25-001742
Chunk: 17

Company: Haymaker Acquisition Corp. 4
Filing Date: 2025-08-13
Form: 10-Q
Item: Part II, Item 1L
Chunk 17
---
Item 1. Legal Proceedings. 

To the knowledge of our Management Team, there is no material litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or against any of our property.

Item 1A. Risk Factors.

As a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Report. For additional risks relating to our operations, see the section titled “Risk Factors” contained in our (i) IPO Registration Statement, (ii) 2024 Annual Report, (iii) Quarterly Reports on Form 10-Q for the quarterly period ended September 31, 2023 and March 31, 2025, as filed with the SEC on November 9, 2023 and May 15, 2025, respectively, and (iv) Definitive Proxy Statement on Schedule 14A, as filed with the SEC on July 1, 2025. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risks could arise that may also affect our ability to consummate an initial Business Combination. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales of Equity Securities

None.

Use of Proceeds

There have been no offerings of registered securities and therefore no planned use of proceeds from such offerings during the quarterly period covered by the Report. For a description of the use of proceeds generated in our Initial Public Offering and Private Placement, see Part II, Item 2 of our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2023, as filed with the SEC on September 8, 2023. There has been no material change in the planned use of proceeds from our Initial Public Offering and Private Placement as described in the IPO Registration Statement. The specific investments in our Trust Account may change from time to time.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

On July 24, 2025, we held the 2025 AGM and our shareholders approved, among other things, the Extension Amendment, which extended the Combination Period for up to twelve times from July 28, 2025 (which was 24 months from the closing of the Initial Public Offering) to July 28, 202